Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST
Clinical trial NCT03858478 · UNKNOWN
Trial details
- NCT number
- NCT03858478
- Sponsor
- Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-18
- Primary completion
- 2021-03-31
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.